FDA Policy On Financial Conflicts Of Public Speakers At Advisory Panels Unchanged
This article was originally published in The Pink Sheet Daily
Executive Summary
In final guidance, the agency has rejected calls by the advocacy group Public Citizen to allow committee members to question open public hearing speakers on their finances.